James Hart, MD
Psychiatry · Franklin, TNNPI 1215915871
Payments from drug & device makers
Across 635 payments — averaging $356.29 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- AbbVie$87K
- Teva Pharmaceuticals USA, Inc.$81K
- Otsuka Pharmaceutical Development & Commercialization, Inc.$12K
- Neurocrine Biosciences, Inc.$11K
- Vanda Pharmaceuticals Inc.$11K
- Supernus Pharmaceuticals, Inc.$8K
- plus $16K from 21 others
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| AbbVie(2 entities) | 31 | $87,226 |
| Teva Pharmaceuticals USA, Inc. | 154 | $81,465 |
| Otsuka Pharmaceutical Development & Commercialization, Inc. | 3 | $12,172 |
| Neurocrine Biosciences, Inc. | 58 | $11,101 |
| Vanda Pharmaceuticals Inc. | 51 | $10,695 |
| Supernus Pharmaceuticals, Inc. | 2 | $8,006 |
| H. Lundbeck A S | 3 | $4,789 |
| Alkermes, Inc. | 56 | $3,526 |
| E.r. Squibb & Sons, L.L.C. | 11 | $2,770 |
| ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.) | 55 | $974 |
| Johnson & Johnson | 63 | $968 |
| Otsuka America Pharmaceutical, Inc. | 33 | $484 |
| Sunovion Pharmaceuticals Inc. | 24 | $465 |
| Takeda Pharmaceuticals U.S.A., Inc. | 21 | $353 |
| Lundbeck LLC | 19 | $342 |
| Avanir Pharmaceuticals, Inc. | 15 | $283 |
| Merck | 11 | $186 |
| Axsome Therapeutics, Inc. | 6 | $109 |
| Eisai Inc. | 5 | $79 |
| Jazz Pharmaceuticals Inc. | 3 | $53 |
| Noven Therapeutics, LLC | 3 | $52 |
| Almatica Pharma LLC | 3 | $42 |
| Luye Pharma (USA) Ltd. | 1 | $28 |
| Harmony Biosciences LLC | 1 | $24 |
| Novartis | 1 | $20 |
| Indivior Inc. | 1 | $17 |
| Adlon Therapeutics L.p. | 1 | $15 |
How this compares
$226,245 in reported general payments places this provider in the 95th percentile of 503 psychiatry providers in Tennessee.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Other psychiatry in Franklin
- Sricharan MoturiFranklin$82K
- William BellFranklin$10K
- Rakesh AminNashville$3M
- Brian BonfardinJohnson City$2.6M
- Paul NewhouseNashville$1.4M
- John FenleyJohnson City$1.4M
- Anita VarmaMemphis$1.3M
- Patricia AndrewsNashville$748K
- David SnowMaryville$605K
- Jonathan BeckerBrentwood$261K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.